AD Friedman
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Immunology top 10%
- Immune Response and Inflammation
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Protein Degradation and Inhibitors 2
- Retinoids in leukemia and cellular processes 2
- Ubiquitin and proteasome pathways 2
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Linda M. Scott (2 shared papers)CI Civin (2 shared papers)Donatella Venturelli (2 shared papers)G Rovera (2 shared papers)Alister C. Ward (1 shared paper)I.P. Touw (1 shared paper)Nicoletta Sacchi (1 shared paper)
- Journals
- Blood (4 papers)Leukemia (2 papers)PubMed (1 paper)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
AD Friedman
7 papers receiving 553 citations
Peers
Comparison fields: 5 of 58
- Hematology 225
- Immunology 217
- Immunology and Allergy 36
- Cancer Research 88
- Molecular Biology 331
Countries citing papers authored by AD Friedman
This map shows the geographic impact of AD Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Friedman more than expected).
Fields of papers citing papers by AD Friedman
This network shows the impact of papers produced by AD Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Friedman. The network helps show where AD Friedman may publish in the future.
Co-authors
The 7 scholars most cited alongside AD Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 367 | |
| 2 | 1999 | 78 | |
| 3 | 2001 | 40 | |
| 4 | 1991 | 38 | |
| 5 | 1992 | 27 | |
| 6 | DNA-binding domain of AML1, expressed in t(8;21) and t(3;21) myeloid leukemias, inhibits PEBP2/CBF DNA-binding but is not sufficient to transform 32D cl3 myeloid cells. | 1996 | 7 |
| 7 | 1991 | 4 |
About AD Friedman
AD Friedman is a scholar working on Molecular Biology, Hematology, Pulmonary and Respiratory Medicine, Nutrition and Dietetics and Immunology, having authored 7 papers that have together received 561 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Protein Degradation and Inhibitors (2 papers), Neonatal Respiratory Health Research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Infant Nutrition and Health (2 papers), Ubiquitin and proteasome pathways (2 papers) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Hematology (225 citations), Immunology (217 citations), Immunology and Allergy (36 citations), Cancer Research (88 citations) and Molecular Biology (331 citations). AD Friedman has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Linda M. Scott, CI Civin, Donatella Venturelli, G Rovera, Alister C. Ward, I.P. Touw and Nicoletta Sacchi. Their work appears in journals such as Blood, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.